Jesse Papenburg, MD, FRCPC, Pediatric Infectious Disease Specialist and Medical Microbiologist
I love to play ultimate frisbee.
2022 McGill Principal’s Prize for Public Engagement through Media, Emerging Researchers Category
2016-2020 Junior Clinical Scholar 1 FRQ-S (Fonds de recherche du Québec - Santé)
2010 AMMI-Canada Post-Residency Fellowship
2010 Royal College of Physicians & Surgeons Canada Detweiler Travelling Fellowship
Assistant Professor, Department of Pediatrics, Faculty of Medicine, McGill University
Associate Member, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University
Junior Scientist, MUHC Research Institute (MUHC-RI): Infectious Disease and Immunity in Global Health (IDIGH) Program, Centre of Outcomes Research and Evaluation (CORE)
Investigator, MUHC Vaccine Study Centre
BSc (Major in Microbiology & Immunology, Minor in Philosophy), McGill University (1998)
MDCM, McGill University (2002)
Pediatrics, Montreal Children's Hospital (2006)
Pediatric Infectious Diseases, Montreal Children's Hospital (2008)
Medical Microbiology, McGill University Health Centre (2008).
Research Fellowship: Epidemiology and Molecular Evolution of Influenza and Other Respiratory Viruses. Centre de recherche en infectiologie de l'Université Laval (2009-11).
MSc in Epidemiology (2011-13): Correlates of Provincial Laboratory Surveillance for Respiratory Viruses. McGill University.
Dr. Jesse Papenburg - IDIGH Program, [email protected]
Dr Papenburg’s research focuses on the epidemiology, diagnosis, treatment, and prevention of severe viral lower respiratory tract infections in children. He actively engages in knowledge translation in his field by contributing to national and provincial guidelines on RSV immunoprophylaxis, influenza antiviral treatment, and SARS-CoV-2 diagnostics and treatment. He is also a voting member of Canada's National Advisory Committee on Immunization (NACI) and chair of NACI’s influenza working group.
- Resource utilization in pediatric acute viral infections;
- Urgent air transfers of children in Canadian Northern communities to tertiary care centres for lower respiratory tract infection;
- Diagnostics and biomarkers to distinguish viral and bacterial acute respiratory infections;
- Diagnostic accuracy of point-of-care tests for influenza and RSV;
- Prevention strategies for viral respiratory infections, including RSV and influenza;
- Clinical impact of molecular diagnostics for respiratory viruses and CNS pathogens;
Respiratory viruses, influenza, respiratory syncytial virus (RSV), children, epidemiology
Mehta K, Morris SK, Bettinger JA, Vaudry W, Jadavji T, Halperin SA, Bancej C, Sadarangani M, Dendukuri N, Papenburg J; Canadian Immunization Monitoring Program Active (IMPACT) Investigators. Antiviral Use in Canadian Children Hospitalized for Influenza. Pediatrics. 2021 Oct;148(4):e2020049672. PMID: 34548379.
Papenburg J, Defoy I, Massé E, Caouette G, Lebel MH. Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study. J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):237-244. PMID: 32530035.
Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, Dittrich S, Yansouni CP. Diagnostic testing for Severe Acute Respiratory Syndrome-related Coronavirus-2: A narrative review. Ann Intern Med. 2020 Jun 2;172(11):726-34. PMID: 32282894.
Burstein B, Plint AC, Papenburg J. Use of radiography in patients diagnosed as having acute bronchiolitis in US emergency departments, 2007-2015. JAMA. 2018 Oct;320(15):1598-1600. PMID: 30326115.
Merckx J, Wali R, Schiller I, Caya C, Gore G, Chartrand C, Dendukuri N, Papenburg J. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared to RT-PCR: systematic review and meta-analysis. Ann Intern Med. 2017 Sept 167(6): 394-409. PMID: 28869986.